Swiss CMO Lonza, which has been searching for a game-changing M&A deal, looks to have unearthed one in contractor Capsugel.

Sanofi recently that it will sell off its generic drug unit in Europe, a decision that will affect two manufacturing plants in the Czech Republic and Romania.

Investors knew that Pfizer’s $14 billion acquisition of Medivation and its prostate cancer drug Xtandi would immediately boost the pharma giant’s earnings, but…

A brand-new contract development and manufacturing organization has broken onto the scene, U.K.-based Sterling Pharma Solutions, which was created from a…

Two of the world’s largest generics makers are looking to lay their hands on the largest generics manufacturing plant in Latin America, sources tell Reuters,…

Since it bought out Ranbaxy Laboratories last year, Sun Pharma has been in the process of trimming back its manufacturing network of nearly 50 plants to a more…

Finland’s Fermion plans to spend €30 million to expand an API plant in Hanko--its largest investment in company history--in a move to support current and…

Mylan has struck a $1 billion deal to get the dermatology business of Renaissance Acquisition Holding. But it is getting more than a portfolio of generic meds…